Health-related quality of life and treatment preferences in adolescents with type 1 diabetes. the VIPKIDS study

V. Cherubini, R. Gesuita, R. Bonfanti, A. Franzese, A. P. Frongia, D. Iafusco, A. Iannilli, F. Lombardo, I. Rabbone, A. Sabbion, A. Salvatoni, A. Scaramuzza, R. Schiaffini, N. Sulli, S. Toni, S. Tumini, A. Mosca, F. Carle

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

A multi-centre, observational, cross-sectional study was carried out to determine whether the health-related quality of life (HRQOL) of adolescents with type 1 diabetes is affected by different insulin treatment systems, and which features of HRQOL are impacted by the respective insulin treatment. The study regarded 577 adolescents, aged 10-17 years, with type 1 diabetes treated with continuous subcutaneous insulin infusion (CSII) (n = 306) or multiple daily injections (MDI) (n = 271). The Insulin Delivery System Rating Questionnaire was validated in Italian and was self-completed by the subjects during a routine visit to the centres. Subjects were compared following the domains of the questionnaire. Good HRQOL was seen in subjects treated with either MDI or CSII. Significant differences were not found in the domains for general diabetes, including diabetes worries, social burden and psychological well-being. Multiple quantile regression analysis showed that CSII confers significant advantages in terms of HRQOL with improvements in treatment satisfaction, perceived clinical efficacy and reduction in treatment interference with daily activities. This favourable impact was more evident in subjects reporting lower HRQOL scores, suggesting that CSII may be especially useful for individuals perceiving a poor HRQOL. Analysis of the domains indicated that CSII was associated with a higher HRQOL than MDI. Life-course HRQOL evaluation using a standardised questionnaire can ensure better chronic disease management. This is particularly important when providing individualised care for adolescents, as they become increasingly responsible for managing their diabetes.

Original languageEnglish
Pages (from-to)43-51
Number of pages9
JournalActa Diabetologica
Volume51
Issue number1
DOIs
Publication statusPublished - Feb 2014

Fingerprint

Type 1 Diabetes Mellitus
Subcutaneous Infusions
Quality of Life
Insulin
Therapeutics
Injections
Disease Management
Chronic Disease
Cross-Sectional Studies
Regression Analysis
Psychology
Surveys and Questionnaires

Keywords

  • CSII
  • Devices
  • Diabetes in childhood
  • Psychological aspects
  • Quality of life

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Health-related quality of life and treatment preferences in adolescents with type 1 diabetes. the VIPKIDS study. / Cherubini, V.; Gesuita, R.; Bonfanti, R.; Franzese, A.; Frongia, A. P.; Iafusco, D.; Iannilli, A.; Lombardo, F.; Rabbone, I.; Sabbion, A.; Salvatoni, A.; Scaramuzza, A.; Schiaffini, R.; Sulli, N.; Toni, S.; Tumini, S.; Mosca, A.; Carle, F.

In: Acta Diabetologica, Vol. 51, No. 1, 02.2014, p. 43-51.

Research output: Contribution to journalArticle

Cherubini, V, Gesuita, R, Bonfanti, R, Franzese, A, Frongia, AP, Iafusco, D, Iannilli, A, Lombardo, F, Rabbone, I, Sabbion, A, Salvatoni, A, Scaramuzza, A, Schiaffini, R, Sulli, N, Toni, S, Tumini, S, Mosca, A & Carle, F 2014, 'Health-related quality of life and treatment preferences in adolescents with type 1 diabetes. the VIPKIDS study', Acta Diabetologica, vol. 51, no. 1, pp. 43-51. https://doi.org/10.1007/s00592-013-0466-x
Cherubini, V. ; Gesuita, R. ; Bonfanti, R. ; Franzese, A. ; Frongia, A. P. ; Iafusco, D. ; Iannilli, A. ; Lombardo, F. ; Rabbone, I. ; Sabbion, A. ; Salvatoni, A. ; Scaramuzza, A. ; Schiaffini, R. ; Sulli, N. ; Toni, S. ; Tumini, S. ; Mosca, A. ; Carle, F. / Health-related quality of life and treatment preferences in adolescents with type 1 diabetes. the VIPKIDS study. In: Acta Diabetologica. 2014 ; Vol. 51, No. 1. pp. 43-51.
@article{b8db0d218163469cbe49bee33a8051d0,
title = "Health-related quality of life and treatment preferences in adolescents with type 1 diabetes. the VIPKIDS study",
abstract = "A multi-centre, observational, cross-sectional study was carried out to determine whether the health-related quality of life (HRQOL) of adolescents with type 1 diabetes is affected by different insulin treatment systems, and which features of HRQOL are impacted by the respective insulin treatment. The study regarded 577 adolescents, aged 10-17 years, with type 1 diabetes treated with continuous subcutaneous insulin infusion (CSII) (n = 306) or multiple daily injections (MDI) (n = 271). The Insulin Delivery System Rating Questionnaire was validated in Italian and was self-completed by the subjects during a routine visit to the centres. Subjects were compared following the domains of the questionnaire. Good HRQOL was seen in subjects treated with either MDI or CSII. Significant differences were not found in the domains for general diabetes, including diabetes worries, social burden and psychological well-being. Multiple quantile regression analysis showed that CSII confers significant advantages in terms of HRQOL with improvements in treatment satisfaction, perceived clinical efficacy and reduction in treatment interference with daily activities. This favourable impact was more evident in subjects reporting lower HRQOL scores, suggesting that CSII may be especially useful for individuals perceiving a poor HRQOL. Analysis of the domains indicated that CSII was associated with a higher HRQOL than MDI. Life-course HRQOL evaluation using a standardised questionnaire can ensure better chronic disease management. This is particularly important when providing individualised care for adolescents, as they become increasingly responsible for managing their diabetes.",
keywords = "CSII, Devices, Diabetes in childhood, Psychological aspects, Quality of life",
author = "V. Cherubini and R. Gesuita and R. Bonfanti and A. Franzese and Frongia, {A. P.} and D. Iafusco and A. Iannilli and F. Lombardo and I. Rabbone and A. Sabbion and A. Salvatoni and A. Scaramuzza and R. Schiaffini and N. Sulli and S. Toni and S. Tumini and A. Mosca and F. Carle",
year = "2014",
month = "2",
doi = "10.1007/s00592-013-0466-x",
language = "English",
volume = "51",
pages = "43--51",
journal = "Acta Diabetologica",
issn = "0940-5429",
publisher = "Springer-Verlag Italia s.r.l.",
number = "1",

}

TY - JOUR

T1 - Health-related quality of life and treatment preferences in adolescents with type 1 diabetes. the VIPKIDS study

AU - Cherubini, V.

AU - Gesuita, R.

AU - Bonfanti, R.

AU - Franzese, A.

AU - Frongia, A. P.

AU - Iafusco, D.

AU - Iannilli, A.

AU - Lombardo, F.

AU - Rabbone, I.

AU - Sabbion, A.

AU - Salvatoni, A.

AU - Scaramuzza, A.

AU - Schiaffini, R.

AU - Sulli, N.

AU - Toni, S.

AU - Tumini, S.

AU - Mosca, A.

AU - Carle, F.

PY - 2014/2

Y1 - 2014/2

N2 - A multi-centre, observational, cross-sectional study was carried out to determine whether the health-related quality of life (HRQOL) of adolescents with type 1 diabetes is affected by different insulin treatment systems, and which features of HRQOL are impacted by the respective insulin treatment. The study regarded 577 adolescents, aged 10-17 years, with type 1 diabetes treated with continuous subcutaneous insulin infusion (CSII) (n = 306) or multiple daily injections (MDI) (n = 271). The Insulin Delivery System Rating Questionnaire was validated in Italian and was self-completed by the subjects during a routine visit to the centres. Subjects were compared following the domains of the questionnaire. Good HRQOL was seen in subjects treated with either MDI or CSII. Significant differences were not found in the domains for general diabetes, including diabetes worries, social burden and psychological well-being. Multiple quantile regression analysis showed that CSII confers significant advantages in terms of HRQOL with improvements in treatment satisfaction, perceived clinical efficacy and reduction in treatment interference with daily activities. This favourable impact was more evident in subjects reporting lower HRQOL scores, suggesting that CSII may be especially useful for individuals perceiving a poor HRQOL. Analysis of the domains indicated that CSII was associated with a higher HRQOL than MDI. Life-course HRQOL evaluation using a standardised questionnaire can ensure better chronic disease management. This is particularly important when providing individualised care for adolescents, as they become increasingly responsible for managing their diabetes.

AB - A multi-centre, observational, cross-sectional study was carried out to determine whether the health-related quality of life (HRQOL) of adolescents with type 1 diabetes is affected by different insulin treatment systems, and which features of HRQOL are impacted by the respective insulin treatment. The study regarded 577 adolescents, aged 10-17 years, with type 1 diabetes treated with continuous subcutaneous insulin infusion (CSII) (n = 306) or multiple daily injections (MDI) (n = 271). The Insulin Delivery System Rating Questionnaire was validated in Italian and was self-completed by the subjects during a routine visit to the centres. Subjects were compared following the domains of the questionnaire. Good HRQOL was seen in subjects treated with either MDI or CSII. Significant differences were not found in the domains for general diabetes, including diabetes worries, social burden and psychological well-being. Multiple quantile regression analysis showed that CSII confers significant advantages in terms of HRQOL with improvements in treatment satisfaction, perceived clinical efficacy and reduction in treatment interference with daily activities. This favourable impact was more evident in subjects reporting lower HRQOL scores, suggesting that CSII may be especially useful for individuals perceiving a poor HRQOL. Analysis of the domains indicated that CSII was associated with a higher HRQOL than MDI. Life-course HRQOL evaluation using a standardised questionnaire can ensure better chronic disease management. This is particularly important when providing individualised care for adolescents, as they become increasingly responsible for managing their diabetes.

KW - CSII

KW - Devices

KW - Diabetes in childhood

KW - Psychological aspects

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=84896697134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896697134&partnerID=8YFLogxK

U2 - 10.1007/s00592-013-0466-x

DO - 10.1007/s00592-013-0466-x

M3 - Article

C2 - 23508374

AN - SCOPUS:84896697134

VL - 51

SP - 43

EP - 51

JO - Acta Diabetologica

JF - Acta Diabetologica

SN - 0940-5429

IS - 1

ER -